Kuopio, Finland

Jukka Ilkka

This inventor holds 1 USPTO granted patent. Top assignee: Santhera Pharmaceuticals (Switzerland) Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jukka Ilkka. Retrieved from https://idiyas.com/inventor/jukka-ilkka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jukka Ilkka: Innovator in Oromucosal Formulations

Introduction

Jukka Ilkka is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oromucosal formulations. His innovative work has led to the creation of a unique patent that addresses specific medical needs.

Latest Patents

Jukka Ilkka holds a patent for an oromucosal formulation and the process for preparing it. This formulation contains as an active ingredient a substituted imidazole derivative, which is designed to enhance therapeutic efficacy. The patent details the specific chemical structure and preparation process, showcasing his expertise in pharmaceutical innovation. He has 1 patent to his name.

Career Highlights

Jukka Ilkka is currently employed at Santhera Pharmaceuticals (Switzerland) Ltd., where he continues to work on advancing pharmaceutical formulations. His role at the company allows him to collaborate with other experts in the field and contribute to the development of innovative treatments.

Collaborations

Throughout his career, Jukka has worked alongside talented colleagues, including Päivi Juujärvi and Juha-Matti Savola. These collaborations have fostered a productive environment for research and development, leading to advancements in pharmaceutical science.

Conclusion

Jukka Ilkka's contributions to oromucosal formulations exemplify his commitment to innovation in the pharmaceutical industry. His work not only highlights his expertise but also reflects the importance of collaboration in achieving significant advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…